Articles with public access mandates - Pierre Laurent-PuigLearn more
Not available anywhere: 17
Immune and stromal classification of colorectal cancer is associated with molecular subtypes and relevant for precision immunotherapy
E Becht, A de Reyniès, NA Giraldo, C Pilati, B Buttard, L Lacroix, J Selves, ...
Clinical cancer research 22 (16), 4057-4066, 2016
Mandates: National Institute of Health and Medical Research, France
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab
B Jacobs, W De Roock, H Piessevaux, R Van Oirbeek, B Biesmans, ...
Journal of clinical oncology 27 (30), 5068-5074, 2009
Mandates: Research Foundation (Flanders)
TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma
J Biton, A Mansuet-Lupo, N Pécuchet, M Alifano, H Ouakrim, J Arrondeau, ...
Clinical Cancer Research 24 (22), 5710-5723, 2018
Mandates: National Institute of Health and Medical Research, France
Immune contexture, immunoscore, and malignant cell molecular subgroups for prognostic and theranostic classifications of cancers
E Becht, NA Giraldo, C Germain, A de Reyniès, P Laurent-Puig, ...
Advances in immunology 130, 95-190, 2016
Mandates: National Institute of Health and Medical Research, France
A study of hypermethylated circulating tumor DNA as a universal colorectal cancer biomarker
S Garrigou, G Perkins, F Garlan, C Normand, A Didelot, D Le Corre, ...
Clinical chemistry 62 (8), 1129-1139, 2016
Mandates: National Institute of Health and Medical Research, France
The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience …
A Mansuet-Lupo, A Bobbio, H Blons, E Becht, H Ouakrim, A Didelot, ...
Chest 146 (3), 633-643, 2014
Mandates: National Institute of Health and Medical Research, France
The soluble α chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer
C Badoual, G Bouchaud, NEH Agueznay, E Mortier, S Hans, A Gey, ...
Cancer research 68 (10), 3907-3914, 2008
Mandates: National Institute of Health and Medical Research, France
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France …
J Taieb, V Taly, J Henriques, C Bourreau, L Mineur, J Bennouna, ...
Clinical Cancer Research 27 (20), 5638-5646, 2021
Mandates: National Institute of Health and Medical Research, France
BCL-2 system analysis identifies high-risk colorectal cancer patients
AU Lindner, M Salvucci, C Morgan, N Monsefi, AJ Resler, M Cremona, ...
Gut 66 (12), 2141-2148, 2017
Mandates: Science Foundation Ireland, Cancer Research UK
Circadian genes polymorphisms, night work and prostate cancer risk: Findings from the EPICAP study
MG Wendeu‐Foyet, S Cénée, Y Koudou, B Trétarre, X Rébillard, ...
International Journal of Cancer 147 (11), 3119-3129, 2020
Mandates: Swiss Cancer League
Association of breast cancer risk with polymorphisms in genes involved in the metabolism of xenobiotics and interaction with tobacco smoking: A gene‐set analysis
T Berrandou, C Mulot, E Cordina‐Duverger, P Arveux, P Laurent‐Puig, ...
International journal of cancer 144 (8), 1896-1908, 2019
Mandates: Agence Nationale de la Recherche, Swiss Cancer League
DNAshell protects DNA stored at room temperature for downstream next-generation sequencing studies
K Washetine, S Heeke, C Ribeyre, C Bourreau, C Normand, H Blons, ...
Biopreservation and biobanking 17 (4), 352-354, 2019
Mandates: Agence Nationale de la Recherche
Impact of single‐nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD‐12/PRODIGE‐2 phase III trial
V Boige, C Mollevi, S Gourgou, D Azria, JF Seitz, M Vincent, L Bigot, ...
International Journal of Cancer 145 (11), 3163-3172, 2019
Mandates: US Department of Defense
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments
C Campani, S Imbeaud, G Couchy, M Ziol, TZ Hirsch, S Rebouissou, ...
Gut 73 (11), 1870-1882, 2024
Mandates: European Commission, Agence Nationale de la Recherche
Cancer colorectal: du consensus moléculaire vers le consensus clinique?
C Pilati, P Laurent-Puig
Innovations & Thérapeutiques en Oncologie 5 (1), 35-38, 2019
Mandates: National Institute of Health and Medical Research, France, Agence Nationale …
Translational epigenetics in precision medicine of colorectal cancer
J Beltrán-García, R Osca-Verdegal, S Mena-Mollá, M Seco-Cervera, ...
Epigenetics in Precision Medicine, 19-41, 2022
Mandates: Government of Spain
Colorectal cancer: from molecular to clinical consensus?
C Pilati, P Laurent-Puig
Innovations & Thérapeutiques en Oncologie 5 (1), 35-38, 2019
Mandates: National Institute of Health and Medical Research, France, Agence Nationale …
Available somewhere: 142
The consensus molecular subtypes of colorectal cancer
J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ...
Nature medicine 21 (11), 1350-1356, 2015
Mandates: US National Institutes of Health, Research Foundation (Flanders), Worldwide …
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ...
Annals of Oncology 27 (8), 1386-1422, 2016
Mandates: Cancer Research UK, National Institute for Health Research, UK
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
E Becht, NA Giraldo, L Lacroix, B Buttard, N Elarouci, F Petitprez, J Selves, ...
Genome biology 17, 1-20, 2016
Mandates: National Institute of Health and Medical Research, France
Publication and funding information is determined automatically by a computer program